Exploring Advances in Blindness Prevention and Treatment Explore the latest Nature Outlook on Vision, supported by Astellas Pharma, highlighting groundbreaking advancements in blindness prevention and treatment, from optogenetic therapies to AI-powered screenings, showcasing the vast potential for impactful collaborations in ophthalmology. Read more.
Next-Generation High-Performance Immunoassays Discover how Japan's cutting-edge immunoassay technologies, led by Fujirebio's innovative systems, are revolutionizing early disease detection and diagnosis, making medical diagnostics more precise and effective.Read more.
Materials Science: Addressing Climate and Health Challenges Materials science is driving innovative solutions to combat climate change and improve health, from advanced batteries for electric vehicles to cooling materials for buildings and enhanced medical diagnostics, fostering both environmental sustainability and economic growth. Read more.
Canada’s Biotechnology Sector: A Global Leader Canada's biotechnology industry is booming, driven by increased government investment and international partnerships, with significant advancements in drug discovery, AI applications, and bioprinted tissue therapeutics, positioning the country as a leader in life sciences and economic growth. Read more.
Nature Custom Media new name We are thrilled to announce the evolution of Nature Research Custom Media into Nature Custom Media, aligning more closely with the Nature brand to offer high-impact content solutions like branded content, webcasts, videos, website development, and events, engaging the global scientific community with unmatched expertise.Read more.
Feature on Biopharma Dealmakers 2025 issues Don't miss the deadlines to participate in our RNA technologies (online collections) in April and Neurodegenerative disorders – including Alzheimer's disease and dementia and/or Aging/Longevity (full issues) in June. Read more.
Feature on Nature Milestones on Quantum Science 2025 Nature Portfolio supports the UN's Year of Quantum Science and Technology with 'Nature Milestones on Quantum,' a series celebrating a century of quantum advancements. Join us in this educational journey and showcase your thought leadership. Contact us for more information!Read more.
Would any of your colleagues or friends benefit from our monthly newsletter? Please invite them to subscribe here.
As a registered user of Nature Portfolio websites, our database indicates that you have opted-in to receive product information and special offers. If you no longer wish to receive these marketing emails from Nature Portfolio please click here to unsubscribe.
If you wish to discontinue all email services from Nature Portfolio please click here to unsubscribe.
Springer Nature Limited is a company incorporated in England & Wales under company number 785998 & whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. Nature Portfolio | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA
If you no longer wish to receive these marketing emails from Nature Portfolio please click here to unsubscribe.
Springer Nature Limited is a company incorporated in England & Wales under company number 785998 & whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. Nature Portfolio | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA
